Format

Send to

Choose Destination
Diabetes Obes Metab. 2018 Jan;20(1):173-177. doi: 10.1111/dom.13060. Epub 2017 Aug 17.

Walnut consumption increases activation of the insula to highly desirable food cues: A randomized, double-blind, placebo-controlled, cross-over fMRI study.

Author information

1
Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Abstract

AIMS:

The use of walnuts is recommended for obesity and type 2 diabetes, although the mechanisms through which walnuts may improve appetite control and/or glycaemic control remain largely unknown.

MATERIALS AND METHODS:

To determine whether short-term walnut consumption could alter the neural control of appetite using functional magnetic resonance imaging, we performed a randomized, placebo-controlled, double-blind, cross-over trial of 10 patients who received, while living in the controlled environment of a clinical research center, either walnuts or placebo (using a validated smoothie delivery system) for 5 days each, separated by a wash-out period of 1 month.

RESULTS:

Walnut consumption decreased feelings of hunger and appetite, assessed using visual analog scales, and increased activation of the right insula to highly desirable food cues.

CONCLUSIONS:

These findings suggest that walnut consumption may increase salience and cognitive control processing of highly desirable food cues, leading to the beneficial metabolic effects observed.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT02673281.

KEYWORDS:

appetite control; obesity therapy; randomised trial; type 2 diabetes

PMID:
28715141
PMCID:
PMC5720909
DOI:
10.1111/dom.13060
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center